Profil
John Mulligan is the founder and CEO of Good Therapeutics, Inc. which was founded in 2016.
He is also the founder of Bonum Therapeutics, Inc.
Aktiva positioner av John Mulligan
| Företag | Position | Start |
|---|---|---|
Good Therapeutics, Inc.
Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Grundare | 2016-01-01 |
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 2 |
|---|---|
Good Therapeutics, Inc.
Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Health Technology |
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Commercial Services |
















